Related Experiment Video
Updated: May 9, 2026
08:40
Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis
Published on: February 28, 2021
Multi-Voxel 1H-MRS in Metachromatic Leukodystrophy
Mitra Assadi1, Dah-Jyuu Wang, Yadira Velazquez-Rodriquez
1Departments of Neurology and Pediatrics, Robert Wood Johnson Medical School.
Journal of Central Nervous System Disease
|August 9, 2013
Summary
Metachromatic leukodystrophy (MLD) involves sulfatide buildup. Brain spectroscopy in children with MLD revealed elevated myoinositol and lactate, suggesting these as potential biomarkers for disease progression.
Area of Science:
- Biochemistry
- Neuroscience
- Medical Imaging
Background:
- Metachromatic leukodystrophy (MLD) is a rare genetic disorder.
- It is defined by the pathological accumulation of sulfatide lipids.
- This accumulation primarily affects the brain and peripheral nervous system.
Purpose of the Study:
- To investigate metabolic alterations in the brains of children with MLD.
- To identify potential biomarkers for monitoring disease progression.
Main Methods:
- Utilized multi-voxel proton magnetic resonance spectroscopy (MRS).
- Analyzed brain metabolite ratios in four pediatric patients diagnosed with MLD.
- Compared findings against established reference values or control groups (implied).
Main Results:
- Observed significantly elevated myoinositol/creatine ratios.
- Detected increased lactate/creatine ratios.
- Found decreased N-acetyl aspartate/creatine ratios, indicating neuronal dysfunction.
Conclusions:
- Elevated myoinositol and lactate levels are likely associated with astrogliosis in MLD.
- These metabolite alterations show promise as reliable biomarkers for tracking MLD progression.
- MRS can provide valuable insights into the biochemical changes occurring in MLD.
